Sequencing Core

测序核心

• 批准号: 8202350
• 负责人: Roger E. Bumgarner
• 金额: $ 8.41万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-08 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8202350
• 关键词: Anatomic Sites; Blood; CCR5 gene; Cell Transplants; Cells; Cerebrospinal Fluid; Clinical; Code; Complementary DNA; DNA; DNA Sequencing Facility; Data; Data Analyses; Evolution; Gagging; Genome; Goals; Gut associated lymphoid tissue; HIV; HIV Infections; Hematopoietic; Individual; Intestines; Knowledge; Measures; Methods; Modeling; Population; Primates; Reading; Regimen; Running; SIV; Sampling; Sequence Analysis; Services; Site; Site-Directed Mutagenesis; Specificity; Testing; Viral; Viral Genome; Viral load measurement; Virus; conditioning; genetic analysis; mutant; simian human immunodeficiency virus

In this core, Dr. Bumgarner's group will be responsible for performing sequencing analysis of viral populations isolated from a primate model of hematopoetic cell transplant (HCT) aimed at a targeted cure for HIV.

在这个核心中，Bumgarner博士的小组将负责对从造血细胞移植（HCT）的灵长类动物模型中分离的病毒群进行测序分析，旨在靶向治疗HIV。